Follistatin 344 For Sale — Research Grade
PX1 Research provides certified, high-purity Follistatin 344 for in vitro and preclinical laboratory investigation. Synthesized in domestic, GMP-compliant facilities, every batch undergoes comprehensive HPLC and mass spectrometry testing to ensure uncompromising analytical consistency. Acquire research-grade Follistatin 344 with lot-specific documentation and same-day dispatch from our California and Arizona fulfillment hubs.
Quick answer
PX1 Research provides certified, high-purity Follistatin 344 for in vitro and preclinical laboratory investigation. Synthesized in domestic, GMP-compliant facilities, every batch undergoes comprehensive HPLC and mass spectrometry testing to ensure uncompromising analytical consistency. Acquire research-grade Follistatin 344 with lot-specific documentation and same-day dispatch from our California and Arizona fulfillment hubs.
Key takeaways
- Follistatin 344 (FST-344) is an autocrine glycoprotein monomer containing 344 amino acids that has emerged as a primary molecular target in cell biology and preclinical musculoskeletal research.
- The biochemical activity of Follistatin 344 is rooted in its unique structural domains, which include an N-terminal domain followed by three follistatin-like (FS) domains.
- When sourcing [research peptides](/research-peptides/all-peptides) for sensitive cellular assays, peptide purity directly correlates with experimental validity.
- In preclinical studies evaluating tissue accretion, protein synthesis, and cellular proliferation, investigators frequently compare the mechanism of Follistatin 344 against other signaling molecules.
Overview of Follistatin 344 in Preclinical Research
Follistatin 344 (FST-344) is an autocrine glycoprotein monomer containing 344 amino acids that has emerged as a primary molecular target in cell biology and preclinical musculoskeletal research. Originally isolated from follicular fluid, follistatin functions as a potent endogenous inhibitor of specific transformational growth factor-beta (TGF-β) superfamily ligands, most notably myostatin (Growth Differentiation Factor 8 or GDF-8) and activin A. In vitro studies demonstrate that by binding directly to these regulatory proteins, Follistatin 344 prevents their interaction with activin type II receptors (ActRIIB), thereby modulating downstream intracellular signaling pathways.
Researchers seeking high-purity follistatin 344 for sale rely on rigorous analytical validation to ensure reproducibility across cellular models. In laboratory settings, FST-344 serves as a crucial reagent for investigating muscle hypertrophy, cellular differentiation, and tissue regeneration mechanisms. Because endogenously produced follistatin undergoes alternative splicing to yield various isoforms, synthesized FST-344 represents a standardized precursor protein used extensively in recombinant assays. Access to standardized peptides through the PX1 Research Library allows investigators to systematically map receptor binding kinetics without the confounding variability introduced by uncharacterized biological extracts.
Molecular Architecture and Inhibitory Mechanism of Action
The biochemical activity of Follistatin 344 is rooted in its unique structural domains, which include an N-terminal domain followed by three follistatin-like (FS) domains. Preclinical structural analysis indicates that the N-terminal and FS1-FS2 domains form a high-affinity binding pocket that engulfs the dimer interface of activin A and myostatin. By sterically blocking the receptor-binding epitopes of GDF-8, Follistatin 344 neutralizes myostatin-mediated activation of Smad2 and Smad3 transcription factors.
In cell culture systems, the suppression of Smad2/3 phosphorylation prevents the downstream transcriptional upregulation of genes responsible for muscle protein degradation. In vitro data indicate that when myostatin signaling is blocked by FST-344, progenitor myoblasts display accelerated fusion indices and elevated expression of myogenic markers such as myogenin and MyoD. Furthermore, unlike shorter C-terminal truncated isoforms (such as FST-288), the full-length 344-amino acid precursor contains a specific C-terminal tail that influences cell surface heparin-binding affinity, making it an ideal candidate for studying autocrine and paracrine sequestration dynamics.
Purity Thresholds, Lot Testing, and Quality Verification
When sourcing research peptides for sensitive cellular assays, peptide purity directly correlates with experimental validity. PX1 Research mandates that every batch of Follistatin 344 meets or exceeds a baseline purity threshold of 98%, verified through high-performance liquid chromatography (HPLC) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS). Analytical chromatograms verify the absence of truncated sequences, deletion peptides, or synthesis byproducts that could induce off-target biological responses.
In addition to structural and sequence verification, every lot of Follistatin 344 is subjected to quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below 0.1 EU/mg. Endotoxin contamination can skew cell culture viability, trigger non-specific inflammatory responses in macrophage assays, and compromise cellular differentiation studies. All analytical testing is executed by independent, ISO 17025-accredited laboratory facilities in the United States, with comprehensive, lot-specific Certificates of Analysis (COAs) publicly accessible prior to purchase.
Comparative Analysis: Follistatin 344 vs. Related Anabolic Research Peptides
In preclinical studies evaluating tissue accretion, protein synthesis, and cellular proliferation, investigators frequently compare the mechanism of Follistatin 344 against other signaling molecules. While FST-344 acts predominantly through ligand neutralization within the TGF-β pathway, alternative compounds operate via distinct receptor cascades. Understanding these mechanistically divergent pathways allows researchers to design targeted comparative assays.
For example, researchers studying local tissue hypertrophy often evaluate myostatin inhibitors alongside truncated insulin-like growth factors such as IGF-1 DES. Whereas Follistatin 344 neutralizes inhibitory growth factors to lift the baseline threshold on muscle growth, IGF-1 analogs directly stimulate the MAPK/ERK and PI3K/Akt pathways to promote cellular proliferation. Similarly, research exploring systemic peptide signaling often pairs myostatin blockade models with secretagogues like CJC-1295 DAC or tissue recovery agents like BPC-157 to evaluate synergistic responses in tendon-to-bone interface models.
In Vitro Application Models and Myoblast Differentiation Assays
Follistatin 344 is extensively utilized in C2C12 murine myoblast cell lines and primary human skeletal muscle myoblast (HSMM) cultures. Preclinical studies suggest that the administration of recombinant FST-344 to myoblast cultures under differentiation conditions results in significant increases in myotube cross-sectional area and multinucleation indices. Investigators routinely measure parameter shifts in creatine kinase activity as a surrogate marker for myotube maturation following follistatin incubation.
Furthermore, in vitro models examining muscle wasting pathologies rely on Follistatin 344 to establish baseline rescue thresholds against catabolic cytokine challenges. Exposure of cell cultures to dexamethasone or tumor necrosis factor-alpha (TNF-α) typically induces marked myotube atrophy; addition of exogenous FST-344 to the culture medium neutralizes concurrent myostatin upregulation, blunting protein degradation pathways. These assays provide critical data regarding the cross-talk between inflammatory signaling and TGF-β family regulation.
Reconstitution Protocol and Solubilization Standards for Laboratory Use
To preserve the tertiary structure and bioactivity of Follistatin 344, precise laboratory reconstitution procedures must be followed. Lyophilized FST-344 powder should be brought to room temperature inside a laminar flow cabinet prior to opening to prevent atmospheric moisture condensation. Reconstitution should be performed using sterile, endotoxin-free water or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the planned cellular assay.
When solubilizing the lyophilized cake, liquid should be gently directed along the inner wall of the glass vial rather than directly onto the peptide powder. Gentle vortexing or slow rotational agitation is recommended; vigorous shaking must be strictly avoided, as mechanical shear stress can disrupt delicate secondary protein folding and lead to irreversible aggregation. For long-term cell culture experiments requiring working concentrations, reconstituting with a carrier protein such as 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) helps prevent non-specific adsorption of the peptide to plastic microplates and storage tubes.
Storage, Thermal Stability, and Handling Practices
Lyophilized Follistatin 344 displays high thermal stability when stored under controlled atmospheric conditions. Upon receipt of shipment, intact vials should be stored in a desiccated environment at -20°C for short-to-medium term research projects, or at -80°C for extended storage exceeding six months. Exposure to light and ambient thermal fluctuations should be minimized to prevent oxidative degradation of sensitive amino acid residues.
Once reconstituted into an aqueous solution, Follistatin 344 exhibits reduced stability compared to its freeze-dried state. Reconstituted stock solutions may be stored at 2°C to 8°C for up to 7 days. For prolonged experimental protocols, the stock solution should be divided into single-use micro-aliquots and frozen at -80°C to eliminate repeated freeze-thaw cycles. Preclinical trial data confirm that multiple freeze-thaw events accelerate polypeptide cleavage and precipitation, leading to inaccurate concentration measurements in quantitative ELISA assays.
Sourcing Verified Follistatin 344: Vendor Qualification Parameters
Selecting a reliable supplier when searching for follistatin 344 for sale requires evaluating specific manufacturing and verification criteria. Research institutions must ensure that candidate vendors synthesize peptides under strict Good Manufacturing Practice (GMP) standards to eliminate heavy metal residues, trifluoroacetate (TFA) salts, and cross-contaminants. Unverified overseas sources frequently deliver peptides containing high TFA levels, which can exhibit cytotoxic effects in delicate primary cell lines.
PX1 Research distinguishes itself by synthesizing all peptides domestically within the United States. Prior to catalog release, every synthesis run undergoes rigorous batch validation performed by third-party analytical labs. Laboratory purchasers can evaluate complete raw spectral data—including high-resolution HPLC chromatograms and mass spectra—to verify exact molecular weight and chemical purity before placing orders. Exploring options through our growth hormone secretagogues and regulatory peptide catalog guarantees full traceability from synthesis to delivery.
Institutional Procurement, Bulk Ordering, and Logistics
PX1 Research is engineered to meet the operational demands of academic institutions, biotechnology firms, and contract research organizations (CROs). To support continuous high-throughput screening and multi-phase research designs, we maintain robust inventory levels of Follistatin 344 across our strategic distribution facilities in California and Arizona. Qualified academic and corporate entities can access specialized pricing structures and dedicated supply agreements via our wholesale portal.
Logistical efficiency is critical for maintaining cold-chain integrity and experimental timelines. Orders placed prior to cut-off times Monday through Friday are processed and dispatched on the same day from our CA or AZ facilities. Lyophilized peptides are packaged in temperature-controlled, shock-absorbent shipping materials to ensure structural stability throughout transit, providing laboratory teams with immediate, reliable access to high-purity research compounds.
Frequently Asked Questions
Is Follistatin 344 approved for human administration?
No. Follistatin 344 provided by PX1 Research is strictly a research-grade chemical intended for in vitro, cell culture, and laboratory research applications only. It is not approved by the FDA for human consumption, medical treatment, diagnosis, or therapeutic use.
What purity level is guaranteed for PX1 Follistatin 344?
Every lot of Follistatin 344 supplied by PX1 Research undergoes HPLC analysis to guarantee a minimum chemical purity of ≥98%. Mass spectrometry is additionally performed to confirm correct sequence identity.
How does PX1 test for endotoxin contamination in peptides?
PX1 utilizes quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing via independent ISO 17025 accredited facilities to ensure endotoxin levels remain below 0.1 EU/mg, preventing cell culture toxicity.
What solvent should be used to reconstitute Follistatin 344 for cell culture?
For standard laboratory assays, sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended. Adding 0.1% BSA can prevent peptide adherence to plastic container walls.
Where are PX1 Research peptides synthesized and shipped from?
All PX1 Research peptides are synthesized in domestic US facilities operating under GMP guidelines. Orders are fulfilled directly from our dispatch centers located in California and Arizona.
What are the recommended storage temperatures for Follistatin 344?
Lyophilized Follistatin 344 should be stored at -20°C for short-term needs or -80°C for long-term storage. Reconstituted liquid aliquots should be kept at -80°C and protected from repeated freeze-thaw cycles.
How fast are Follistatin 344 orders dispatched?
Orders placed Monday through Friday before our daily cut-off time are processed and shipped same-day from our CA or AZ logistics facilities.
Can universities or research labs obtain bulk or wholesale accounts?
Yes. Qualified institutional buyers, university labs, and corporate researchers can set up institutional accounts with bulk tier pricing via our wholesale procurement portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.